S&P 500
(0.25%) 5 487.03 points
Dow Jones
(0.15%) 38 835 points
Nasdaq
(0.03%) 17 862 points
Oil
(-0.01%) $81.56
Gas
(0.41%) $2.92
Gold
(-0.20%) $2 342.20
Silver
(-0.30%) $29.48
Platinum
(-0.14%) $975.80
USD/EUR
(0.07%) $0.931
USD/NOK
(0.08%) $10.58
USD/GBP
(0.04%) $0.787
USD/RUB
(-0.14%) $85.25

Realtime updates for Kuros Biosciences AG [KURN.SW]

Exchange: SIX Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated18 Jun 2024 @ 11:30

-6.55% CHF 11.42

Live Chart Being Loaded With Signals

Commentary (18 Jun 2024 @ 11:30):
Our systems believe the stock currently is undervalued by -0.60% compare to its pairs and should correct upwards.

Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development of biopharmaceutical products for tissue repair and bone regeneration in the United States, the European Union, and internationally...

Stats
Today's Volume 377 623
Average Volume 251 697
Market Cap 423.69M
EPS CHF-0.240 ( Q4 | 2023-12-31 )
Next earnings date ( CHF0 ) 2024-08-07
Last Dividend CHF0 ( N/A )
Next Dividend CHF0 ( N/A )
P/E -30.05
(Sector) 0
(Industry) 0
ATR14 CHF0.0730 (0.64%)
ADXN.SW 0.00%
BANB.SW -0.70%
BSLN.SW 0.85%
COPN.SW -0.42%
IDIA.SW 3.02%
KURN.SW -6.55%
LONN.SW 0.89%
MOLN.SW 10.05%
NOVN.SW -0.42%
NWRN.SW 5.78%
OBSN.SW -76.92%
POLN.SW -6.91%
RLF.SW -4.27%
ROG.SW 0.98%
SANN.SW 1.24%
SFZN.SW 0.32%
SKIN.SW 9.85%
TECN.SW 0.92%
Correlation (AI algo v.1.1b): Undervalued: -0.60% CHF11.27 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.20 (neutral)
Short: -0.79 (moderate negative)
Signal:(44.96) Neutral

Kuros Biosciences AG Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Kuros Biosciences AG Correlation - Currency/Commodity

The country flag -0.54
( weak negative )
The country flag -0.27
( neutral )
The country flag 0.67
( moderate )
The country flag 0.49
( neutral )
The country flag -0.38
( neutral )
The country flag -0.52
( weak negative )

Kuros Biosciences AG Financials

Annual 2023
Revenue: CHF33.56M
Gross Profit: CHF27.78M (82.78 %)
EPS: CHF-0.380
FY 2023
Revenue: CHF33.56M
Gross Profit: CHF27.78M (82.78 %)
EPS: CHF-0.380
FY 2023
Revenue: CHF0
Gross Profit: CHF0 (0.00 %)
EPS: CHF0
FY 2022
Revenue: CHF17.99M
Gross Profit: CHF10.77M (59.87 %)
EPS: CHF-0.430

Financial Reports:

No articles found.

Kuros Biosciences AG Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Kuros Biosciences AG

Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development of biopharmaceutical products for tissue repair and bone regeneration in the United States, the European Union, and internationally. It operates through Medical Devices, Pharmaceuticals, and Legacy Portfolio. The company's orthobiologics pipeline products include MagnetOs Granules and MagnetOs Putty in EU and US for the treatment of orthopedics, spinal, and dental problems. Its fibrin/PTH orthobiologics pipeline products comprise KUR-111, which has completed Phase 2b clinical trial for the treatment of tibial plateau fractures; and KUR-113, which completed Phase 2b clinical trial for the treatment of tibial shaft fractures, as well as is in the Phase II trial for the treatment of spinal interbody fusion. The company's sealants pipeline products include Neuroseal EU and US, synthetic tissue sealant for the prevention of cerebrospinal fluid leakage following cranial or spinal surgery. It has collaboration with Checkmate Pharmaceuticals LLC for the development of CYT003 for the treatment of oncology. The company is headquartered in Schlieren, Switzerland.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 1.034903049469 seconds
Number of API calls: 3
Number of DB calls: 9